Home/Filings/4/0001209191-10-061530
4//SEC Filing

ACURA PHARMACEUTICALS, INC 4

Accession 0001209191-10-061530

CIK 0000786947operating

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 8:01 AM ET

Size

6.1 KB

Accession

0001209191-10-061530

Insider Transaction Report

Form 4
Period: 2010-12-16
REDDICK ANDREW D
DirectorPresident and CEO
Transactions
  • Award

    Stock Options

    2010-12-16+83,33383,333 total
    Exercise: $3.02Exp: 2020-12-15Common Stock (83,333 underlying)
Footnotes (3)
  • [F1]Exercise price is closing price of Issuer's common stock on December 16, 2010.
  • [F2]one-twenty-fourth of shares underlying options vest and are exercisable on the last day of each month commencing December 31, 2010 and ending on November 30, 2012.
  • [F3]Not Applicable.

Issuer

ACURA PHARMACEUTICALS, INC

CIK 0000786947

Entity typeoperating
IncorporatedNY

Related Parties

1
  • filerCIK 0000786947

Filing Metadata

Form type
4
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 8:01 AM ET
Size
6.1 KB